217 related articles for article (PubMed ID: 23027959)
21. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.
Krishnan N; Krishnan K; Connors CR; Choy MS; Page R; Peti W; Van Aelst L; Shea SD; Tonks NK
J Clin Invest; 2015 Aug; 125(8):3163-77. PubMed ID: 26214522
[TBL] [Abstract][Full Text] [Related]
22. TRPC3 channels are necessary for brain-derived neurotrophic factor to activate a nonselective cationic current and to induce dendritic spine formation.
Amaral MD; Pozzo-Miller L
J Neurosci; 2007 May; 27(19):5179-89. PubMed ID: 17494704
[TBL] [Abstract][Full Text] [Related]
23. The ups and downs of BDNF in Rett syndrome.
Sun YE; Wu H
Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
[TBL] [Abstract][Full Text] [Related]
24. RNAi-induced down-regulation of Mecp2 expression in the rat brain.
Jin J; Bao X; Wang H; Pan H; Zhang Y; Wu X
Int J Dev Neurosci; 2008 Aug; 26(5):457-65. PubMed ID: 18396005
[TBL] [Abstract][Full Text] [Related]
25. BDNF induces calcium elevations associated with IBDNF, a nonselective cationic current mediated by TRPC channels.
Amaral MD; Pozzo-Miller L
J Neurophysiol; 2007 Oct; 98(4):2476-82. PubMed ID: 17699689
[TBL] [Abstract][Full Text] [Related]
26. A small-molecule TrkB ligand restores hippocampal synaptic plasticity and object location memory in Rett syndrome mice.
Li W; Bellot-Saez A; Phillips ML; Yang T; Longo FM; Pozzo-Miller L
Dis Model Mech; 2017 Jul; 10(7):837-845. PubMed ID: 28679669
[TBL] [Abstract][Full Text] [Related]
27. Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice.
Kline DD; Ogier M; Kunze DL; Katz DM
J Neurosci; 2010 Apr; 30(15):5303-10. PubMed ID: 20392952
[TBL] [Abstract][Full Text] [Related]
28. Acute intermittent hypoxia-induced expression of brain-derived neurotrophic factor is disrupted in the brainstem of methyl-CpG-binding protein 2 null mice.
Vermehren-Schmaedick A; Jenkins VK; Knopp SJ; Balkowiec A; Bissonnette JM
Neuroscience; 2012 Mar; 206():1-6. PubMed ID: 22297041
[TBL] [Abstract][Full Text] [Related]
29. Cell-Genotype Specific Effects of Mecp2 Mutation on Spontaneous and Nicotinic Acetylcholine Receptor-Evoked Currents in Medial Prefrontal Cortical Pyramidal Neurons in Female Rett Model Mice.
Asgarihafshejani A; Nashmi R; Delaney KR
Neuroscience; 2019 Aug; 414():141-153. PubMed ID: 31299345
[TBL] [Abstract][Full Text] [Related]
30. Restoration of motor learning in a mouse model of Rett syndrome following long-term treatment with a novel small-molecule activator of TrkB.
Adams I; Yang T; Longo FM; Katz DM
Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 33361117
[TBL] [Abstract][Full Text] [Related]
31. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons.
Yazdani M; Deogracias R; Guy J; Poot RA; Bird A; Barde YA
Stem Cells; 2012 Oct; 30(10):2128-39. PubMed ID: 22865604
[TBL] [Abstract][Full Text] [Related]
32. Screening of Transient Receptor Potential Canonical Channel Activators Identifies Novel Neurotrophic Piperazine Compounds.
Sawamura S; Hatano M; Takada Y; Hino K; Kawamura T; Tanikawa J; Nakagawa H; Hase H; Nakao A; Hirano M; Rotrattanadumrong R; Kiyonaka S; Mori MX; Nishida M; Hu Y; Inoue R; Nagata R; Mori Y
Mol Pharmacol; 2016 Mar; 89(3):348-63. PubMed ID: 26733543
[TBL] [Abstract][Full Text] [Related]
33. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
[TBL] [Abstract][Full Text] [Related]
34. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.
Kondo M; Gray LJ; Pelka GJ; Christodoulou J; Tam PP; Hannan AJ
Eur J Neurosci; 2008 Jun; 27(12):3342-50. PubMed ID: 18557922
[TBL] [Abstract][Full Text] [Related]
35. MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production.
Abuhatzira L; Makedonski K; Kaufman Y; Razin A; Shemer R
Epigenetics; 2007; 2(4):214-22. PubMed ID: 18075316
[TBL] [Abstract][Full Text] [Related]
36. Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons.
Sampathkumar C; Wu YJ; Vadhvani M; Trimbuch T; Eickholt B; Rosenmund C
Elife; 2016 Oct; 5():. PubMed ID: 27782879
[TBL] [Abstract][Full Text] [Related]
37. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
38. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice.
Wang H; Chan SA; Ogier M; Hellard D; Wang Q; Smith C; Katz DM
J Neurosci; 2006 Oct; 26(42):10911-5. PubMed ID: 17050729
[TBL] [Abstract][Full Text] [Related]
40. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
